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Abstract
Background: Detection of vascular invasion by hematoxylin and eosin staining is the current pathological assessment
practice to diagnose breast carcinoma. However, conventional hematoxylin and eosin staining failed to distinguish
between blood vessel invasion and lymphatic vessel invasion. Both are important prognostic criteria however with
different outcomes. The aim of this study is to distinguish between blood vessel invasion and lymphatic vessel invasion
using conventional assessment and immunohistochemical markers. The prognostic significance of both circulatory
invasions in invasive breast carcinoma was also investigated.
Methods: Consecutive sections of breast carcinoma samples from 58 patients were stained with CD34 and D240 to
stain blood and lymphatic vessels respectively. Hematoxylin and eosin staining was carried out on another consecutive
section as conventional staining.
Results: Although blood vessel density is higher in the sections (median = 10.3 vessels) compared to lymphatic
vessel density (median = 0.13), vessel invasion is predominantly lymphatic invasion (69.8 and 55.2% respectively).
Interestingly, peritumoral lymphatic vessel density and peritumoral lymphatic invasion was significantly associated
with distant metastasis (p = 0.049 and p = 0.05 respectively). The rate of false positive and false negative interpretation
by hematoxylin and eosin was 46.7 and 53.3% respectively.
Conclusions: Lymphatic vessel invasion is a strong prognostic markers of breast carcinoma invasion and the use of
immunohistochemical markers increase the rate and accuracy of detection.
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Background
Breast carcinoma is one of the leading cancer worldwide
with more than 190,000 new cases reported each year in
the US [1]. From this figure, the estimated deaths is
about 21%. The prognosis of breast cancer is based on
the age and menopausal status of the patients, tumor
size, histological types and grade, hormone and growth
factor receptors and vascular invasion [2].
Currently, vascular invasion is detected microscopically
as the presence of tumor cells within the blood or lymph-
atic vessels using haematoxylin and eosin (H&E) staining
[2]. Patients with positive vascular invasion often has
poorer prognosis than those with negative invasion. The
presence of vascular invasion was also associated with
axillary lymph node involvement, systemic relapse and
local recurrence [3, 4]. However, conventional assessment
of vascular invasion by H&E stained slides was reported
to have high rate of false interpretation. Retraction arte-
facts of the tissue sections tend to be reported as positive
invasion while packed tumor cells in a vessel may be
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missed, leading to false positive and false negative obser-
vation of the tissue respectively. There was a low level of
concordence (kappa = 0.3) between two observers in
reporting vascular invasion of H&E stained tissue section
[5]. In addition, H&E staining failed to distinguish be-
tween lymphatic vessel invasion and blood vessel invasion
in patients’ samples.
D240 is a monoclonal antibody that bind to an O-linked
sialoglycoprotein on lymphatic endothelial cells but not
on blood endothelial cells. Therefore, D240 antibody has
been used as reliable marker to evaluate lymphatic inva-
sion in many research settings [6, 7]. The commercially
available D240 antibody binds to a fixation resistant epi-
tope on podoplanin molecules, an integral transmembrane
glycoprotein. Ultrastructural analysis revealed the predo-
minat localisation to the luminal surface of lymphatic
vessels. CD34 is a common endothelial marker used to
detect the presence of blood vessels. This antibody detects
a 110 kDa transmembrane glycoprotein expressed on
endothelial cells, embryonic fibroblasts and some nervous
tissues [8].
The aim of this study is to compare the incidence of
lymphatic vessel invasion and blood vessel invasion in
breast carcinoma cohort between conventional H&E
staining and immunohistochemical staining. The signifi-
cance of using immunohistochemical markers in relation
to adverse clinicopathological criteria is also evaluated.
Methods
Patients and specimens
This study was conducted on 58 consecutive formalin
fixed paraffin embedded (FFPE) archival specimens of
breast carcinoma obtained from Universiti Sains Malaysia
Hospital. Clinical characteristics of the patients and
tumors are summarized in Table 1.
Immunohistochemistry
Two consecutive FFPE breast carcinoma sections from
each patient were stained with CD34 and D240 to assess
blood vessels and lymphatic vessels respectively. Staining
optimization was conducted on breast sections before
using them in the main cohort. 4 μm thick whole
sections from each specimen were deparaffinized in two
xylene baths for 5 min each and then rehydrated in a
series of descending ethanol concentrations (100, 90, 70,
50 and 30% in water for 1 min at each concentration).
Antigen retrieval was carried out in 0.01 mol/L-1
sodium citrate buffer (pH6) in a microwave for 20 min;
10 min at full power (750 W) followed by 10 min at low
power (450 W). Endogenous hydrogen peroxidase activ-
ity was then blocked in 0.3% hydrogen peroxide in
methanol for 10 min. Sections were incubated with the
primary antibody diluted in antibody diluent (DAKO,
Denmark) (1:100 for CD34 and D2-40) for 1 h at room
temperature. Unbound primary antibody was washed with
TBS prior to the addition of HRP-labeled polymer for
30 min. Sections were then washed and immunohisto-
chemical reactions were developed using 3, 3′ diamino-
benzidine (Liquid DAB+ Substrate Chromogen System,
DAKO, K3468) for 7 min.
Counterstained with haematoxylin was carried out for
3 min and rinsed off under running tap water. Sections
were dehydrated in a series of ascending ethanol con-
centrations (30,50,70, 90 and 100% in water for 1 min at
each concentration), fixed in xylene and mounted with
DPX. Sections were left to dry overnight before viewing
under the microscope. Tonsil sections were used as both
positive and negative controls each time staining was
conducted. The procedure as above was applied for posi-
tive controls. For negative controls, primary antibody
was omitted.
Microscopic analysis
All microscopic analysis was carried out using light
microscope (Olympus, Japan).
Assessment of microvessel density and lymphatic vessel
density
Microvessel density was assessed by counting three
hotspots with the highest number of vessels at 100×
magnification. The mean value of the hotspots was
used in the analysis. For lymphatic vessel density, the
positively stained D240 vessels were counted manually
across the tissue section. This ensure the accuracy of
result as lymphatic vessels are present in much lower
density that blood vessel density. For vessel density,
both the peritumoral and intratumoral area were
counted. Intratumoral was defined as the area within
the tumor while peritumoral was defined as the per-
ipheral area at 1 microscopic field of view (×200)
from the intratumoral area.
Assessment of vascular invasion
Figure 1 shows the examples of immunohistochemistry
staining with D240 antibody. Lymphatic vessel invasion
was identified as the presence of tumor cells within a
D2-40 stained vessel. As CD34 can also stain a subset of
lymphatic vessels, blood vessel invasion was defined
when tumour cells were detected in CD34 positive but
D240 negative vessels. The frequency of vascular inva-
sion detected by H&E staining was compared with that
detected by IHC. False positive cases were recorded
when H&E sections were positive for vascular invasion
but negative in IHC. False negatives were recorded when
vascular invasion was negative in the H&E sections but
positive in IHC. 20% of the specimens were randomly
chosen and analysed by second scorer blinded to the
results to measure concordance between observers.
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Statistical analysis
Vessels density was classified into high and low cat-
egory based on the median value. Vessel invasion was
divided into negative and positive groups and used as
a basis to determine association between all parame-
ters. The relationship between vascular invasion, ves-
sels density and clinical criteria were assessed using
chi square test (Fisher exact if the cell count was less
than 5). Multivariate analyses were carried out using
binomial logistic regression and multiple regression
analysis based on the type of variables. Some tumors
were not scored because of missing tissue and lack of
peritumoral area. P value of less than 0.05 determined
significant relationship. Variations between observers
were measured using kappa score. Statistical analysis
was carried out using IBM SPSS Statistic 24.
Fig. 1 Example of true positive lymphatic vessel invasion determined in D2-40 stained tissue. H&E stained tissue scored as positive lymphovascular
invasion (a). At the same field of microscopic field view (200× magnification), lymphatic vessel invasion was clearly observed in D2-40 stained tissue
(b). In CD34 stained tissue (c), blood vessel invasion was scored as negative
Table 1 Clinicopathological characteristics of breast carcinoma patients and tumors
Clinical criteria Frequency, n (%) Clinical criteria Frequency, n (%)
Age of diagnosis Recurrence
≤40 4 (6.9) No 56 (96.6)
≥40 54 (93.1) Yes 2 (3.4)
Ethnicity Estrogen Receptor
Malay 54 (93.1) Positive 32 (55.2)
Chinese 4 (6.9) Negative 26 (44.8)
Tumor Size (mm) Progesteron Receptor
<30 11 (19.0) Positive 28 (48.3)
30 ≤ × < 60 27 (46.6) Negative 30 (51.7)
>60 17 (29.3)
No data 3 (5.1)
Tumor Grading Lymph nodes involvement
Grade I 10 (17.2) 1 19 (32.8)
Grade II 27 (46.6) 2-4 6 (10.3)
Grade III 16 (27.6) >4 16 (27.6)
Not determined 5 (8.6) Not involved 17 (29.3)
Distant Metastasis Lymphovascular Invasion (H&E)
Yes 15 (25.9) Positive 26 (44.8)
No 37 (63.8) Negative 28 (48.3)




Norhisham et al. BMC Clinical Pathology  (2017) 17:2 Page 3 of 7
Results
Distribution of lymphatic and blood vessels
Microvessel density ranged from 5 to 26 vessels with a
median of 10.3 vessels. Peritumoral lymphatic vessel dens-
ity and intratumoral lymphatic vessel density showed a
median of 0.052/mm2 and 0.078/mm2 respectively.
Frequency of lymphatic and blood vessels invasion
25.7% (n = 15) showed no vascular invasion on both
intratumoral and peritumoral area. Of the 43 samples
with vascular invasion, 69.8% (n = 30) showed lymph-
atic vessel invasion. Of the LVI positive specimens,
33.3% (n = 10), 26.7% (n = 8) and 40.0% (n = 12) were
intratumoral invasion, peritumoral invasion and both
intratumoral and peritumoral invasion respectively.
In comparison to IHC staining, only 55.2% (n = 32)
showed invasion positive in H&E stained slides. When
compared with all cases, 7 cases were false positive while
8 cases showed false negative results. Figure 1 shows the
example of positive D2-40 staining which was scored as
vascular invasion negative in H&E section. Figure 2
shows the determination of lymphatic vessel invasion
positive which was scored as invasion positive in H&E
staining. The kappa scores of invasion using immunohis-
tochemical markers between observers were 0.87 and
0.88 for CD34 and D240 respectively. The kappa score
of H&E staining between observers was 0.61.
Association of lymphatic and blood vessel density with
clinical criteria
Table 2 shows the association of lymphatic vessel density
with clinical criteria. Peritumoral and total lymphatic ves-
sel density was significantly associated with age (p = 0.020
and 0.017 respectively) Total lymphatic vessel density was
also associated with grade (p = 0.018). Interestingly, peri-
tumoral lymphatic vessel density was significantly associ-
ated with distant metastasis (p = 0.049). Blood vessel
density was not associated with all clinical criterias.
However, in multivariate analysis none of these vari-
ables retain their significant association (peritumoral
lymphatic vessel density: age p = 0.820, distant metas-
tasis p = 0.291 and total lymphatic vessel density:
grade p = 0.728; age p = 0.916).
Association of lymphatic and blood vessel invasion with
clinical criteria
Table 3 shows the association of lymphatic vessel invasion
with clinical criteria. Peritumoral lymphatic invasion was
significantly associated with age (p = 0.012) and distant
metastasis (p = 0.05). Blood vessel invasion was not signifi-
cantly associated with all clinical criterias. In multivariate
analysis, only age retain the significant association with
peritumoral lymphatic vessel invasion (p = 0.001).
Discussion
The aim of this study was to compare the incidence of
lymphatic invasion and blood invasion in breast carcin-
oma cohort between conventional H&E staining and
immunohistochemical staining. It also aimed to investi-
gate the association of lymphatic/blood vessel density
and invasion with adverse clinical criteria.
Previous studies showed that lymphatic invasion and
blood vessel invasion cannot be distinguished when
H&E staining was used in tissue biopsy [8, 9]. The pres-
ence of lymphatic and blood endothelial cells specific
markers, D2-40 and CD34, respectively made the identi-
fication of these vessels possible. It is important to know
which type of invasion occurs in individual patients,
which has been shown in this study because blood and
lymphatic vessel invasion have different prognostic out-
comes. In addition, personalized therapy could be
designed to cater the needs of every patients based on
their invasion routes. Furthermore, this study demon-
strated that the concordance score between observers
with the usage of immunohistochemical markers is
excellent compared to the lower score when reporting
Fig. 2 H&E (a), D2-40 (b) and CD-34 (c) staining of consecutive tissue section. This sample was scored as lymphovascular invasion negative by
H&E. However, CD34 staining (c) clearly showed the presence of tumor cells within CD34 stained vessel and was scored as blood vessel invasion
positive. Lymphatic invasion was scored as negative (b). Noted that IHC was able to distinguih between lymphatic and blood vessel invasion.
(200× magnification)
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vascular invasion of H&E stained tissue section [5].
These showed that immunohistochemical markers could
be used in clinical setting with patients samples to mini-
mized the rate of error.
In this study, it was shown that although the frequency
of blood vessel density was higher compared to lymph-
atic vessel density, the incidence of lymphatic vessel
invasion exceeded that of blood vessel invasion. Clearly,
breast carcinoma preferentially used lymphatic vessels as
a route of metastasis. Similar data were also reported by
previous study showing that lymphatic vessel invasion
incidences exceeded of that blood vessel invasions which
were 35 and 16% respectively. Mohammed and colleagues
also showed significant invasions of the lymphatics (97%)
compared to the blood vessels (3%). These results and our
results indicated clearly that breast carcinoma prefer-
entially used lymphatic vessels as a route of metasta-
sis. It was not known what drive tumor cells to
invade lymphatic vessels when there are higher num-
ber of blood vessel in the tumoral area. One explan-
ation is the anatomical structure of the lymphatic
vessel itself which would not offer a significant barrier
for the entry of tumor cells [10]. The lack of
basement membrane and supporting structure in the
lymphatic vasculature may ease the intravasation of
tumor cells into the lymphatic circulation. In con-
trary, lymphatic endothelium might also play an ac-
tive role in tumor cells recruitment. They may secrete
chemokines that attracted the tumor cells to the
lymphatic capillaries. Chemokines receptor-ligand re-
lationships are important to regulate leukocytes traf-
ficking and this relationship was hypothesized to be
exploited by cancer cells to modulate entry into the
lymphatic circulation [11, 12].
The presence of intratumoral lymphatic vessel inva-
sion has been debatable as it was thought that lymph-
atic vessel could not penetrate the high pressure
environment inside the tumor mass. With the discovery
of new molecular markers and better imaging systems,
the presence of intratumoral lymphatics has been re-
ported [13]. In this study, we reported the presence of
intratumoral lymphatic vessel invasion however no sig-
nificant association was observed with any clinical
criteria under study. Previous study has demonstrated
the association between intratumoral lymphatic inva-
sion with markers of aggressiveness [14] which was
Table 2 Association of lymphatic vessel density with clinical criteria
Total LVD Intra-tumoral LVD Peri-tumoural LVD
Low High p-value Low High p-value Low High p-value
Age <40 0 (0.0) 4 (13.3) 0.020 2 (7.4) 2 (6.9) 0.941 0 (0.0) 4 (13.8) 0.017
≥40 27 (100.0) 26 (86.7) 25 (92.6) 27 (93.1) 28 (100.0) 2 (86.2)
Tumor size <30 2 (7.7) 9 (31.0) 0.080 3 (11.1) 8 (28.6) 0.255 3 (11.1) 8 (28.6) 0.255
30 ≤ × < 60 15 (57.7) 12 (41.4) 15 (55.6) 12 (42.9) 15 (55.6) 12 (42.9)
60 ≥ 9 (34.6) 8 (27.6) 9 (33.3) 8 (28.6) 9 (33.3) 8 (28.6)
Grade I 2 (7.7) 8 (26.7) 0.018 1 (3.7) 9 (31.0) 0.030 13 (11.1) 7 (24.1) 0.079
II 13 (50.0) 14 (46.7) 15 (55.6) 12 (41.4) 14 (51.9) 13 (44.8)
III 11 (42.3) 5 (16.7) 10 (37.0) 6 (20.7) 10 (37.0) 6 (20.7)
No grade 0 3 (10.0) 1 (3.7) 2 (6.9) 0 3 (10.3)
Distant metastasis Yes 7 (25.9) 8 (27.6) 0.989 8 (29.6) 7 (23.3) 0.065 7 (25.0) 8 (27.6) 0.049
No 18 (66.7) 19 (65.5) 19 (70.4) 19 (63.3) 21 (75.0) 17 (58.6)
Not determine 2 (7.4) 2 (6.9) 0 4 (13.3) 0 4 (13.8)
Recurrence No 26 (96.3) 29 (96.7) 0.940 27 (100) 27 (93.1) 0.1 27 (96.4) 28 (96.6) 0.980
Yes 1 (3.7) 1 (3.3) 0 2 (6.9) 1 (3.6) 1 (3.4)
ER Positive 16 (61.5) 16 (55.2) 0.632 16 (61.5) 15 (53.6) 0.554 17 (63.0) 15 (53.6) 0.480
Negative 10 (38.5) 13 (44.8) 10 (38.5) 13 (46.4) 10 (37.0) 13 (46.4)
PR Positive 15 (55.6) 13 (44.8) 0.422 13 (48.1) 14 (50.0) 0.891 16 (57.1) 12 (42.9) 0.284
Negative 12 (44.4) 16 (55.2) 14 (51.9) 14 (50.0) 12 (42.9) 16 (57.1)
Lymph nodes involvement 0 8 (29.6) 11 (37.9) 0.374 8 (30.8) 11 (37.9) 0.678 7 (25.0) 12 (42.9) 0.266
1 3 (11.1) 3 (10.3) 3 (11.5) 3 (10.3) 4 (14.3) 2 (7.1)
2 to 4 6 (22.2) 10 (34.5) 6 (23.1) 10 (31.0) 7 (25) 9 (32.1)
>4 10 (37.0) 5 (17.2) 9 (34.6) 6 (20.7) 10 (35.7) 5 (17.9)
*Bold datas refer to statistically significant association (p<0.05)
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not observed in this cohort perhaps due to the num-
ber of samples used.
The clear association observed between peritumoral
lymphatic vessel density and invasion with distant me-
tastasis indicates that peritumoral lymphatic vessels have
important role in breast carcinoma metastasis to second-
ary organs. Distant metastasis is a major factor that lead
to poor prognosis of cancer patients. Statistics shows
that 90% of cancer-related death occurs as a result of
metastasis [15]. The highly significant association
between these two variables may indicate that targeted
therapy directed to peritumoral density could be de-
signed to reduce metastatic dissemination of cancer cells
especially in breast carcinoma patients.
Conclusions
In conclusion, although blood vessel density in breast
carcinoma patients is higher compared to lymphatic
vessel density, vascular invasion in breast carcinoma is
predominantly lymphatic vessel invasion. The fact that
peritumoral lymphatic vessel invasion was strongly cor-
related with distant metastasis shows that it is a strong
predictor of breast carcinoma outcome. This study
should be repeated in larger cohort with relapse-free
survival and overall survival data. We strongly reccom-
mended that IHC markers be used alongside H&E
staining to improve the detection rate and false inter-
pretation of tissue samples.
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Table 3 Association of lymphatic vessel invasion with clinical criteria
Intra-tumoral LVI Peri-tumoral LVI Total LVI
Positive Negative p-value Positive Negative p-value Positive Negative p-value
Age <40 2 (7.1) 2 (7.1) 1.0 4 (14.8) 0 (0) 0.012 4 (10.5) 0 (0) 0.065
≥40 26 (92.9) 26 (92.9) 23 (85.2) 30 (100) 34 (89.5) 19 (100)
Tumor size <30 7 (25) 4 (14.8) 0.548 4 (14.8) 7 (25) 0.636 9 (23.7) 2 (11.8) 0.497
30≤ × < 60 12 (42.9) 15 (55.6) 14 (51.9) 13 (46.4) 17 (44.7) 10 (58.8)
60 ≥ 9 (32.1) 8 (29.6) 9 (33.3) 8 (28.6) 12 (31.6) 5 (29.4)
Grade I 3 (10.7) 7 (25.0) 0.387 5 (18.5) 5 (17.2) 0.197 5 (13.2) 5 (27.8) 0.607
II 14 (50.0) 13 (46.4) 15 (55.6) 12 (41.4) 19 (50) 8 (44.4)
III 10 (35.7) 6 (21.4) 7 (25.9) 9 (31.0) 12 (31.6) 4 (22.2)
No grade 1 (3.33) 2 (7.1) 0 3 (10.3) 2 (5.3) 1 (5.6)
Distant metastasis Yes 9 (32.1) 6 (21.4) 0.432 7 (25.9) 8 (26.7) 0.05 11 (28.9) 4 (21.1 0.607
No 18 (64.3) 19 (67.9) 20 (74.1) 18 (60.0) 25 (65.8) 13 (68.4)
Not determine 1 (3.6) 3 (10.7) 0 4 (13.3) 2 (5.3) 2 (10.5)
Recurrence No 26 (92.9) 28 (100) 0.92 27 (100) 28 (93.3) 0.105 36 (94.7) 19 (100) 0.198
Yes 2 (7.1) 0 0 2 (6.7) 2 (5.3) 0
ER Positive 16 (59.3) 15 (55.6) 0.632 15 (57.7) 17 (58.6) 0.944 21 (56.8) 11 (61.1) 0.738
Negative 11 (40.7) 12 (44.4) 11 (42.3) 2 (41.4) 16 (43.2) 7 (38.9)
PR Positive 13 (46.4) 14 (51.9) 0.687 13 (48.1) 15 (51.7) 0.789 17 (44.7) 11 (61.1) 0.251
Negative 15 (53.6) 13 (48.1) 14 (51.9) 14 (48.3) 21 (55.3) 7 (38.9)
Lymph nodes involvement 0 10 (37.0) 9 (32.1) 0.983 7 (25.9) 12 (41.4) 0.088 13 (35.1) 6 (31.6) 0.763
1 3 (11.1) 3 (10.7) 1 (3.7) 5 (17.2) 3 (8.1) 3 (15.8)
2 to 4 7 (25.9) 8 (28.6) 11 (40.7) 5 (17.2) 10 (27) 6 (31.6)
>4 7 (25.9) 8 (28.6) 8 (29.6) 7 (24.1) 11 (29.7) 4 (21.1)
*Bold datas refer to statistically significant association (p<0.05)
Norhisham et al. BMC Clinical Pathology  (2017) 17:2 Page 6 of 7
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethical approval for this study was granted by the Human Research Ethics
Committee, Universiti Sains Malaysia (304/PPSK/61312137). The need for
individual informed consent was waived because of the use of archival
materials.
Received: 24 February 2016 Accepted: 30 January 2017
References
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics,
2008. CA: A Cancer Journal for Clinicians CA: Cancer J Clin. 2008;58:26.
2. Dobi A, et al. Breast cancer under 40 years of age: increasing number and
worse prognosis. Pathol Oncol Res. 2011;17(2):425–8.
3. Storr SJ, et al. Objective assessment of blood and lymphatic vessel invasion
and association with macrophage infiltration in cutaneous melanoma. Mod
Pathol. 2011;25:493–504.
4. Longatto-Filho A, et al. Lymphatic vessel density and epithelial D2-40
immunoreactivity in pre-invasive and invasive lesions of the uterine cervix.
2007. p. 45–51.
5. Mohammed R, et al. Improved methods of detection of lymphovascular
invasion demonstrate that it is the predominant method of vascular
invasion in breast cancer and has important clinical consequences.
Am J Surg Pathol. 2007;31:9.
6. Mohammed RAA, et al. Objective assessment of lymphatic and blood
vascular invasion in lymph node-negative breast carcinoma: findings from a
large case series with long-term follow-up. J Pathol. 2011;223(3):358–65.
7. Doeden K, et al. Lymphatic invasion in cutaneous melanoma is associated
with sentinel lymph node metastasis. J Cutan Pathol. 2009;36(7):772–80.
8. Essner R. Sentinel lymph node biopsy and melanoma biology. 2006. p.
2320s–5s.
9. El-Gohary YM, et al. Prognostic significance of intratumoral and peritumoral
lymphatic density and blood vessel density in invasive breast carcinomas.
2008. p. 578–86.
10. Witte M, et al. Structure function relationships in the lymphatic system and
implications for cancer biology. Cancer Metastasis Rev. 2006;25(2):159–84.
11. Kawai Y, et al. Chemokine CCL2 facilitates ICAM-1-mediated interactions of
cancer cells and lymphatic endothelial cells in sentinel lymph nodes. Cancer
Sci. 2009;100(3):419–28.
12. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium.
Ann N Y Acad Sci. 2008;1131(1):119–33.
13. Ji RC, Eshita Y, Kato S. Investigation of intratumoural and peritumoural
lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced
tumours. Int J Exp Pathol. 2007;88(4):257–70.
14. Straume O, Akslen LA. Lymphatic vessel density and prognosis in cutaneous
melanoma. Br J Cancer. 2004;91(6):1224–5.
15. Parkin DM, et al. Fifty years of cancer incidence. Int J Cancer. 2010;127(12):
2918–27.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Norhisham et al. BMC Clinical Pathology  (2017) 17:2 Page 7 of 7
